MedPath

Safety and efficacy assessment of Product on ski

Not Applicable
Registration Number
CTRI/2022/02/040653
Lead Sponsor
Kama Ayurveda Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Having moderate to severe hair fall.

2. Having Moderate to severe dandruff (where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4

is Severe)

3. Suffering with hair thinning on subject assessment basis.

For female: Having at least shoulder length hair.

Having washed their hair with provided neutral shampoo, 48 hours before the first day of the

study with the provided nuetral shampoo.

Having untangled their hair at home, 3 hours prior coming to the site for observations, the first

day of the study.

Exclusion Criteria

1. Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze).

2. Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study.

3. Having surgery history on the scalp (micro transplants â?¦)

4. In the previous 6 months, Having undergone the Minoxidil treatments, Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide), Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids,Having modified her hormonal contraception.

5. In the previous 3 months, Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc), Having taken a food supplement with an anti hair loss claim, Having taken an iron based treatment

6. In the previous 15 days, Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath